Treatment of herpes simplex virus infection: rationale for occlusion.

Asha R. Patel, Paolo Romanelli, Brenda Roberts, Robert Kirsner

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Orofacial herpes is a widespread benign malady that is also commonly known as herpes labialis or cold sores. Herpes of this type is generally caused by herpes simplex virus type 1 (HSV-1) and, to a lesser degree, herpes simplex virus type 2 (HSV-2), both of which are DNA viruses. The clinical presentation of herpetic lesions is normally located on mucocutaneous areas of the face and may eventually erode and ulcerate, leaving wounds that are known to be difficult to successfully treat. Focus of treatment has been related to treatment of the viral infection, and limited attention has focused on the resultant wounds. Clinical observation and recent histologic evaluation has demonstrated these wounds to extend through a disrupted cutaneous basement membrane into the dermis, suggesting that HSV is capable of causing partial-thickness wounds. This observation suggests a role for occlusion in the treatment of herpetic-induced partial-thickness wounds because occlusion is well recognized as the treatment of choice for other types of partial-thickness wounds.

Original languageEnglish
Pages (from-to)408-412
Number of pages5
JournalAdvances in skin & wound care
Volume20
Issue number7
DOIs
StatePublished - Jul 1 2007

Fingerprint

Virus Diseases
Simplexvirus
Wounds and Injuries
Herpes Labialis
DNA Viruses
Human Herpesvirus 2
Human Herpesvirus 1
Dermis
Basement Membrane
Observation
Skin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treatment of herpes simplex virus infection : rationale for occlusion. / Patel, Asha R.; Romanelli, Paolo; Roberts, Brenda; Kirsner, Robert.

In: Advances in skin & wound care, Vol. 20, No. 7, 01.07.2007, p. 408-412.

Research output: Contribution to journalArticle

@article{0d506676fa074a40a3eb266b33ff3b5f,
title = "Treatment of herpes simplex virus infection: rationale for occlusion.",
abstract = "Orofacial herpes is a widespread benign malady that is also commonly known as herpes labialis or cold sores. Herpes of this type is generally caused by herpes simplex virus type 1 (HSV-1) and, to a lesser degree, herpes simplex virus type 2 (HSV-2), both of which are DNA viruses. The clinical presentation of herpetic lesions is normally located on mucocutaneous areas of the face and may eventually erode and ulcerate, leaving wounds that are known to be difficult to successfully treat. Focus of treatment has been related to treatment of the viral infection, and limited attention has focused on the resultant wounds. Clinical observation and recent histologic evaluation has demonstrated these wounds to extend through a disrupted cutaneous basement membrane into the dermis, suggesting that HSV is capable of causing partial-thickness wounds. This observation suggests a role for occlusion in the treatment of herpetic-induced partial-thickness wounds because occlusion is well recognized as the treatment of choice for other types of partial-thickness wounds.",
author = "Patel, {Asha R.} and Paolo Romanelli and Brenda Roberts and Robert Kirsner",
year = "2007",
month = "7",
day = "1",
doi = "10.1097/01.ASW.0000280199.58260.62",
language = "English",
volume = "20",
pages = "408--412",
journal = "Advances in Skin and Wound Care",
issn = "1527-7941",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Treatment of herpes simplex virus infection

T2 - rationale for occlusion.

AU - Patel, Asha R.

AU - Romanelli, Paolo

AU - Roberts, Brenda

AU - Kirsner, Robert

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Orofacial herpes is a widespread benign malady that is also commonly known as herpes labialis or cold sores. Herpes of this type is generally caused by herpes simplex virus type 1 (HSV-1) and, to a lesser degree, herpes simplex virus type 2 (HSV-2), both of which are DNA viruses. The clinical presentation of herpetic lesions is normally located on mucocutaneous areas of the face and may eventually erode and ulcerate, leaving wounds that are known to be difficult to successfully treat. Focus of treatment has been related to treatment of the viral infection, and limited attention has focused on the resultant wounds. Clinical observation and recent histologic evaluation has demonstrated these wounds to extend through a disrupted cutaneous basement membrane into the dermis, suggesting that HSV is capable of causing partial-thickness wounds. This observation suggests a role for occlusion in the treatment of herpetic-induced partial-thickness wounds because occlusion is well recognized as the treatment of choice for other types of partial-thickness wounds.

AB - Orofacial herpes is a widespread benign malady that is also commonly known as herpes labialis or cold sores. Herpes of this type is generally caused by herpes simplex virus type 1 (HSV-1) and, to a lesser degree, herpes simplex virus type 2 (HSV-2), both of which are DNA viruses. The clinical presentation of herpetic lesions is normally located on mucocutaneous areas of the face and may eventually erode and ulcerate, leaving wounds that are known to be difficult to successfully treat. Focus of treatment has been related to treatment of the viral infection, and limited attention has focused on the resultant wounds. Clinical observation and recent histologic evaluation has demonstrated these wounds to extend through a disrupted cutaneous basement membrane into the dermis, suggesting that HSV is capable of causing partial-thickness wounds. This observation suggests a role for occlusion in the treatment of herpetic-induced partial-thickness wounds because occlusion is well recognized as the treatment of choice for other types of partial-thickness wounds.

UR - http://www.scopus.com/inward/record.url?scp=35348925371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348925371&partnerID=8YFLogxK

U2 - 10.1097/01.ASW.0000280199.58260.62

DO - 10.1097/01.ASW.0000280199.58260.62

M3 - Article

C2 - 17620742

AN - SCOPUS:35348925371

VL - 20

SP - 408

EP - 412

JO - Advances in Skin and Wound Care

JF - Advances in Skin and Wound Care

SN - 1527-7941

IS - 7

ER -